Randomized parallel-group trial of lutein supplementation for macular pigment optical density and visual function in the patients with unilateral age-related macular degeneration

Randomized parallel-group trial of lutein supplementation for macular pigment optical density and visual function in the patients with unilateral age-related macular degeneration - Randomized parallel-group trial of lutein supplementation in AMD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027962

Enrollment

Registered

2017-06-28

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related macular degeneration

Interventions

20mg Lutein supplemenation covered by beeswax 20mg Lutein supplemenation covered by glycerol ester

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fello eyes with unilateral age-related macular degeneration. No fundus abnormality or age-related maculopathy

Exclusion criteria

Exclusion criteria: ocular media dicrepancy to disturb measuremant of macular pigment optical density. high myopia lutein intake within 3 months lutein allergy

Design outcomes

Primary

Measure	Time frame
macular pigment density, serum lutein concentration, contrast sensitivity at 3 months and 6 months after lutein intake.	—

Countries

Japan

Contacts

Public ContactMIKI SAWA

Sakai City Medical Center Eye center

sawamikimd@gmail.com072-272-1199

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026